Maximus, Inc. filings document the regulatory record of a public government-services contractor with common stock listed under MMS. Its 8-K reports cover quarterly and annual operating results, financial condition, earnings guidance, capital-return actions, stock repurchase authorizations and senior officer changes.
The company’s proxy materials describe board elections, auditor ratification, advisory executive-compensation votes, equity compensation disclosures and shareholder voting results. Together, the filings address Maximus’s governance structure, executive compensation, common-stock capital actions and formal disclosures related to its U.S. Federal Services, U.S. Services and Outside the U.S. operating segments.
MAXIMUS, Inc. (MMS) reported a Form 4 transaction for its Chief of Human Resources, Michelle Link. On 11/24/2025, she received a grant of 6,013 restricted stock units (RSUs) of MAXIMUS common stock at a price of $0, reflecting an equity award rather than a purchase.
Following this grant, she beneficially owned 19,521.065 shares of MAXIMUS common stock in direct ownership. The RSUs vest on a three-year ratable schedule, with vesting dates on 09/30/2026, 09/30/2027, and 09/30/2028, and may be deferred for a longer period if elected under the award terms. Each RSU represents a contingent right to receive one share of common stock.
MAXIMUS, Inc. (MMS) reported an equity award to a senior executive. Principal Accounting Officer Theresa D. Golinvaux received a grant of 2,565 restricted stock units (RSUs) of common stock on 11/24/2025 at a price of $0 per share. These RSUs are scheduled to vest in four equal annual installments on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029, with the possibility of deferred vesting at her election under the award terms. After this grant, she beneficially owns 12,814.213 shares of MAXIMUS common stock in total.
Maximus, Inc. (MMS) files its 2025 Form 10-K as a tech-enabled services provider to government agencies, focused on health, human services, and technology modernization. The company operates through three segments: U.S. Federal Services, which generated 56% of 2025 revenue; U.S. Services, with 32%; and Outside the U.S., with 11%. Work centers on large eligibility, enrollment, clinical assessment, employment, and digital contact-center programs.
Maximus’ business is highly concentrated: in 2025 about 55% of revenue came from the U.S. federal government, 33% from state and local agencies, and roughly 60% from its ten largest contracts, with about one-fifth tied to a single federal agency. The filing highlights contract, funding, and rebid risks; expanding use of AI with evolving regulation; and ongoing cybersecurity threats, including a prior material incident in 2023. As of September 30, 2025, the company had about 37,200 employees and 9,300 contingent workers, and there were 54,461,507 shares of common stock outstanding as of November 12, 2025.
Maximus, Inc. filed a current report to note that on November 20, 2025 it issued a press release announcing its financial results for the quarter and fiscal year ended September 30, 2025. The press release, which contains the detailed results, is furnished as Exhibit 99.1 to the report rather than being treated as formally filed under securities law.
Victory Capital Management, Inc. filed Amendment No. 3 to Schedule 13G reporting its beneficial ownership in Maximus, Inc. (MMS) common stock. The firm reported 17,364 shares, representing 0.03% of the class as of 09/30/2025.
Victory Capital reported sole voting power over 17,364 shares and sole dispositive power over 17,364 shares, with no shared voting or dispositive power. The filer is identified as an investment adviser under Rule 13d-1(b) and certified the securities were acquired and are held in the ordinary course of business without the purpose or effect of influencing control.
Theresa D. Golinvaux, listed as Principal Accounting Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 09/30/2025 on a Form 4. The filing shows 1,206.759 shares of common stock were disposed of at a price of $91.37; the form explains these shares were surrendered to satisfy withholding tax related to the vesting of restricted stock units (RSUs). After the reported disposition, the reporting person beneficially owns 10,249.213 shares, which includes previously reported RSU awards totaling 5,628.387 RSUs and accrued dividend equivalents with varying distribution schedules. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 10/02/2025.
Michelle Link, Chief of Human Resources at MAXIMUS, Inc. (MMS), reported changes in beneficial ownership on a Form 4. On 09/30/2025 she surrendered 2,255.654 shares to satisfy withholding taxes from vested restricted stock units at a price of $91.37, leaving 15,118.065 shares reported immediately after that transaction. On 10/01/2025 she sold 1,610 shares at $90.86, reducing her reported beneficial ownership to 13,508.065 shares. The filing notes prior RSU awards representing 8,551.266 RSUs with dividend equivalents previously reported and that the sales on 10/01/2025 were executed under a 10b5-1 trading plan adopted on 12/06/2024. The Form is signed by an attorney-in-fact on behalf of the reporting person on 10/02/2025.
John T. Martinez, Chief Legal Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 09/30/2025 disposing of 3,017.119 shares of common stock at $91.37 per share. The filing explains those shares were surrendered to satisfy withholding tax from the vesting of restricted stock units (RSUs). After the reported transaction the reporting person beneficially owns 15,199.192 shares, which includes 13,230.101 previously reported RSUs and accrued dividend equivalent rights with varying distribution schedules.
MAXIMUS, Inc. (MMS) filed a Form 144 notifying the proposed sale of 1,610 common shares held at Fidelity Brokerage Services with an aggregate market value of $146,284.60. The shares represent vested restricted stock acquired and paid as compensation on 09/30/2025. The filing lists approximately 56,349,629 shares outstanding for the issuer and an approximate sale date of 10/01/2025 on the NYSE. No securities were reported sold by the filer in the past three months. The notice includes the filer’s representation that they do not possess undisclosed material adverse information about the issuer.
MAXIMUS, Inc. announced an increase to its existing stock purchase program and said it intends to buy shares opportunistically in the open market, under 10b5-1 plans, or via privately negotiated transactions. The company specified the program has no set purchase amount or expiration date and may be extended, modified, suspended or discontinued at its discretion. A press release describing the increase is filed as Exhibit 99.1 to this Current Report. The filing includes standard forward-looking statements language and points investors to the company’s Annual Report for additional risk factors and disclosures.